Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease

Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease Deborah K. Armstrong Oncologist 2002; 7(Suppl 5): 20-28 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Better appreciate the challenges faced in managing treatment of patients with ovarian cancer. Describe the factors that impact on the design of long-term treatment strategies for patients with relapsed ovarian cancer. Describe important disease management issues, including when to initiate treatment, which treatments to consider and why, and patient education. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Sept. 24, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Sept. 24, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.

Click Here to return to the complete course listing of Current Perspectives in the Treatment of Ovarian Cancer: An Update on the Role of Topotecan